高级检索
当前位置: 首页 > 详情页

CTGF-mediated ERK signaling pathway influences the inflammatory factors and intestinal flora in ulcerative colitis

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Department of Gastroenterology, China-Japan Friendship Hospital, Beijing, 100029, PR China
出处:
ISSN:

关键词: Ulcerative colitis CTGF EKR Inflammatory factors Intestinal flora

摘要:
Objective: To examine the effect of connective tissue growth factor (CTGF)-mediated ERK signaling pathway on the inflammatory response and intestinal flora in ulcerative colitis (UC). Methods: CTGF expression was determined through immunohistochemistry in UC and colon polyp patients. Dextran sulfate sodium (DSS) was used to construct UC models. Wild-type (WT) and CTGF(-/-) deficient (CTGF(-/-)) mice were randomly divided into WT/CTGF(-/-) + saline, WT/CTGF(-/-) + DSS, and WT/CTGF(-/-) + DSS + U0126 (ERK pathway inhibitor) groups. HE staining was conducted to observe the pathological changes in intestinal mucosa. The quantity of intestinal flora was tested in the feces. ELISA, qRT-PCR, and Western blotting were used to detect related-molecules expressions. Results: CTGF was up-regulated in the intestinal mucosa of UC patients in relation to the severity and grade. Moreover, UC patients showed enhanced the expressions of p-ERK/ERK and pro-inflammatory factors (IL-1 beta, IL-6, TNF-alpha, MPO), increased the quantity of Bacteriodes fragilis (B. fragilis) and Escherichia coll. (E. coil), and decreased Bifidobacterium and Lactobacillus. CTGF and pERK/ERK expressions were increased in DSS-induced WT mice, but the pERK expression was lower in CTGF(-/-) + DSS group than that in the WT + DSS group. U0126 decreased the expressions of pro-inflammatory factors and improved the intestinal flora in WT mice induced with DSS. No significant differences were found in the above indexes between CTGF(-/-) + DSS group and WT + DSS + U0126 group. Conclusion: Inhibiting CTGF could improve inflammatory response and intestinal flora to partially reverse DSS induced UC via blocking ERK signaling pathway.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 3 区 医学
小类 | 3 区 医学:研究与实验 3 区 药学
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 医学:研究与实验 2 区 药学
JCR分区:
出版当年[2017]版:
Q2 PHARMACOLOGY & PHARMACY Q2 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q1 MEDICINE, RESEARCH & EXPERIMENTAL Q1 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2017版] 出版当年五年平均[2013-2017] 出版前一年[2016版] 出版后一年[2018版]

第一作者:
第一作者单位: [1]Department of Gastroenterology, China-Japan Friendship Hospital, Beijing, 100029, PR China
通讯作者:
通讯机构: [1]Department of Gastroenterology, China-Japan Friendship Hospital, Beijing, 100029, PR China [*1]Department of Gastroenterology, China-Japan Friendship Hospital, No. 2, Yinghua East Street, Chaoyang District, Beijing, 100029, PR China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)